Edesa Biotech (NASDAQ:EDSA) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.45) by 37.78 percent. This is a 41.67 percent increase over losses of $(0.48) per share from the same period last year.

• No comments yet. Be the first to comment!